Electronic Biosciences, Inc.
San Diego, CA Electronic Biosciences, Inc.
- UEI
- FLHHE89XH2H5
- CAGE
- 3ENS0
- Primary NAICS
- 541330 Engineering Services
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 15970 Bernardo Center Dr, San Diego, CA 92127, USA
- Website
- electronicbio.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Unified nanopore platform for simultaneous DNA, RNA, and protein sequencing | Interior Business Center | $2,999,975 | |
| Next-generation oncoproteomic sequencing and precision profiling - project summary proteins are the essential workhorses… | National Cancer Institute | $418,854 | |
| Spinseq - project summary RNA sequencing technologies are crucial for understanding gene expression, regulation, and the… | National Human Genome Research Institute | $383,482 | |
| Direct proteolytic machine assessments for unfolding and sequencing proteins - project summary protein sequencing is a… | National Institute of General Medical Sciences | $350,000 | |
| High-resolution pseudouridine and M6A sequencing through advanced nanopore adduct analysis - project summary the… | National Institute of General Medical Sciences | $350,000 |
About Electronic Biosciences, Inc.
Electronic Biosciences, Inc., based in San Diego, California, is a for-profit biotechnology company that develops nanopore-based sequencing and diagnostic platforms for federal research agencies as a prime recipient of federal grants, with no federal contract prime awards or subcontract work in its recent footprint. The company competes exclusively under SBIR and STTR grant programs through the National Institutes of Health and allied federal research agencies, with no set-aside designations applicable to grant recipients.
Electronic Biosciences' capability portfolio centers on single-molecule sequencing technologies and point-of-care diagnostic assays, grounded in nanopore analytical platforms. Representative work spans protein sequencing (a $418 thousand 2026 Cancer Biology Research grant from the National Cancer Institute for next-generation oncoproteomic sequencing using nanopore strategies to detect protein variants and post-translational modifications), RNA modification detection (a Phase I SBIR award from the National Human Genome Research Institute in 2025 for SpinSeq, a platform for direct RNA sequencing with preserved modification detection), and clinical diagnostics (a $389 thousand SBIR Phase I award from the National Cancer Institute completed September 2025 for at-home prostate-specific antigen testing). The company also develops enzyme-based protein sequencing systems, extracellular vesicle characterization platforms, and point-of-care assays for immunosuppressant drug monitoring and Type 1 diabetes autoantibody detection.
Customer concentration sits heavily with the National Institutes of Health ecosystem. The National Human Genome Research Institute leads by award count with 17 grants, followed by eleven NIH awards unspecified to subsidiary institutes and ten National Cancer Institute awards carrying $938 thousand in combined potential value. The Department of Homeland Security Science and Technology Directorate anchors the largest single dollar value at $4.5 million across one award, with the Defense Advanced Research Projects Agency accounting for $2.4 million across three awards and the Army Medical Command holding $1.1 million across three awards. The top five customer agencies account for 68% of awards; NIH-wide entities account for the majority of the grant pipeline.
Activity has been consistent but modest. Electronic Biosciences received five awards in 2022, eight in 2023, four in 2024, and four in 2025, with one award in the first half of 2026. Seven awards face ultimate completion within the next twenty-four months, representing potential recompete opportunity. Combined potential value across all 71 awards totals $9.5 million, though obligated dollars of $56.8 million reflect prior invoicing across the portfolio's life. The company operates exclusively as a prime recipient of federal grants under SBIR Phase I and Phase II actions and STTR collaborative awards; it carries no federal contract prime vehicle positions and no subcontractor engagements in the source record.
Quick answers
What is Electronic Biosciences, Inc.'s UEI?
Electronic Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is FLHHE89XH2H5.
What is Electronic Biosciences, Inc.'s CAGE code?
Electronic Biosciences, Inc.'s CAGE code is 3ENS0.
What is Electronic Biosciences, Inc.'s primary NAICS code?
Electronic Biosciences, Inc.'s primary NAICS code is 541330 (Engineering Services).
Where is Electronic Biosciences, Inc. located?
Electronic Biosciences, Inc.'s physical address in SAM.gov is 15970 Bernardo Center Dr, San Diego, CA 92127, USA.
Is Electronic Biosciences, Inc. registered in SAM.gov?
Electronic Biosciences, Inc.'s SAM.gov registration expired on September 10, 2026.
What is Electronic Biosciences, Inc.'s most recent federal award?
Electronic Biosciences, Inc.'s most recent federal contract award is Unified nanopore platform for simultaneous DNA, RNA, and protein sequencing (140D0426C0135), from Interior Business Center, on September 9, 2026.
On GovTribe
See Electronic Biosciences, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors